Health Care Utilization in Patients with Gout

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 6, 2011, Pages 501-511

  Singh, Jasvinder A ^a   Sarkin, A ^b   Shieh, M ^b   Khanna, D ^c   Terkeltaub, R ^b,d   Lee, S J ^b,d   Kavanaugh, A ^d   Hirsch, J D ^d,e  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Gout; Gout severity; Health care utilization; Predictors; Resource utilization

Indexed keywords

URIC ACID;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GENDER; GENERAL PRACTITIONER; GOUT; HEALTH CARE UTILIZATION; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; PHYSICIAN ASSISTANT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOLOGY; URGENT CARE UTILIZATION; URIC ACID BLOOD LEVEL;

COMORBIDITY; DELIVERY OF HEALTH CARE; FEMALE; GOUT; HEALTH PERSONNEL; HUMANS; MALE; OUTPATIENT CLINICS, HOSPITAL; PRIMARY HEALTH CARE; SEVERITY OF ILLNESS INDEX; UNITED STATES; URBAN HEALTH;

EID: 79955976943     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.07.001     Document Type: Article

References (29)

1. Kramer H.M., Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002, 40(1):37-42.
2. Kim K.Y., Ralph Schumacher H., Hunsche E., Wertheimer A.I., Kong S.X. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003, 25(6):1593-1617.
3. Brook R.A., Kleinman N.L., Patel P.A., Melkonian A.K., Brizee T.J., Smeeding J.E., et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006, 22(7):1381-1389.
4. Wu E.Q., Patel P.A., Yu A.P., Mody R.R., Cahill K.E., Tang J., et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008, 14(2):164-175.
5. Hanly J.G., Skedgel C., Sketris I., Cooke C., Linehan T., Thompson K., et al. Gout in the elderly-a population health study. J Rheumatol 2009, 36(4):822-830.
6. Singh J.A., Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilization in US veterans. Ann Rheum Dis 2008, 67(9):1310-1316.
7. Halpern R., Fuldeore M.J., Mody R.R., Patel P.A., Mikuls T.R. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol 2009, 15(1):3-7.
8. Hirsch J.D., Lee S.J., Terkeltaub R., Khanna D., Singh J., Sarkin A., et al. Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol 2008, 35(12):2406-2414.
9. Wallace S.L., Robinson H., Masi A.T., Decker J.L., McCarty D.J., Yu T.F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20(3):895-900.
10. Ragazzini J.R., Bergen A.R. A mathematical technique for the analysis of linear systems. Proc IRE 1954, 42(11):1645-1651.
11. Shoji A., Yamanaka H., Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004, 51(3):321-325.
12. Cohen J., Cohen P., West S., Aiken L. Applied multiple regression/correlation analysis for the behavioral sciences 2003, Lawrence Erlbaum Associates, Hillsdale (NJ). 2nd ed.
13. Arromdee E., Michet C.J., Crowson C.S., O'Fallon W.M., Gabriel S.E. Epidemiology of gout: is the incidence rising?. J Rheumatol 2002, 29(11):2403-2406.
14. Bull P.W., Scott J.T. Intermittent control of hyperuricemia in the treatment of gout. J Rheumatol 1989, 16(9):1246-1248.
15. Borstad G.C., Bryant L.R., Abel M.P., Scroggie D.A., Harris M.D., Alloway J.A. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004, 31(12):2429-2432.
16. Becker M.A., Schumacher H.R., Wortmann R.L., MacDonald P.A., Eustace D., Palo W.A., et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005, 353(23):2450-2461.
17. Clarke A.E., Esdaile J.M., Bloch D.A., Lacaille D., Danoff D.S., Fries J.F. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993, 36(11):1548-1559.
18. Lubeck D.P., Brown B.W., Holman H.R. Chronic disease and health system performance. Care of osteoarthritis across three health services. Med Care 1985, 23(3):266-277.
19. Lubeck D.P., Spitz P.W., Fries J.F., Wolfe F., Mitchell D.M., Roth S.H. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 1986, 29(4):488-493.
20. Reijneveld S.A., Stronks K. The validity of self-reported use of health care across socioeconomic strata: a comparison of survey and registration data. Int J Epidemiol 2001, 30(6):1407-1414.
21. Cleary P.D., Jette A.M. The validity of self-reported physician utilization measures. Med Care 1984, 22(9):796-803.
22. Roberts R.O., Bergstralh E.J., Schmidt L., Jacobsen S.J. Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol 1996, 49(9):989-995.
23. Bergmann M.M., Byers T., Freedman D.S., Mokdad A. Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults. Am J Epidemiol 1998, 147(10):969-977.
24. Fisher M.A., Taylor G.W., Shelton B.J., Debanne S.M. Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults. BMC Public Health 2007, 7:33.
25. Manuel D.G., Lim J.J., Tanuseputro P., Stukel T.A. How many people have had a myocardial infarction?. Prevalence estimated using historical hospital data. BMC Public Health 2007, 7:174.
26. Margolis K.L., Lihong Q., Brzyski R., Bonds D.E., Howard B.V., Kempainen S., et al. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 2008, 5(3):240-247.
27. Rosamond W.D., Sprafka J.M., McGovern P.G., Nelson M., Luepker R.V. Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry. Epidemiology 1995, 6(1):67-69.
28. Simpson C.F., Boyd C.M., Carlson M.C., Griswold M.E., Guralnik J.M., Fried L.P. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 2004, 52(1):123-127.
29. Tisnado D.M., Adams J.L., Liu H., Damberg C.L., Chen W.P., Hu F.A., et al. What is the concordance between the medical record and patient self-report as data sources for ambulatory care?. Med Care 2006, 44(2):132-140.